Patents by Inventor Kathleen Dorothy McCarthy

Kathleen Dorothy McCarthy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938136
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: March 26, 2024
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy Mccarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse
  • Publication number: 20200323856
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Application
    Filed: November 15, 2019
    Publication date: October 15, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem ALSENZ, Olaf GRASSMANN, Peter KUEHL, Friedrich METZGER, Kathleen Dorothy MCCARTHY, Eduardo Paulo Morawski VIANNA, Marvin Lloyd WOODHOUSE
  • Publication number: 20190247405
    Abstract: The present invention relates to olesoxime for use in the treatment of spinal muscular atrophy (SMA), its pharmaceutical composition to be used in the treatment of SMA, its methods of treatment thereof.
    Type: Application
    Filed: November 27, 2018
    Publication date: August 15, 2019
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Thomas Blaettler, Kathleen Dorothy McCarthy, Patricia Sanwald Ducray, Franziska Schaedeli Stark
  • Publication number: 20180289713
    Abstract: The present invention provides compounds of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof for use in the treatment, prevention and/or delay of progression of amyotrophic lateral sclerosis (ALS). Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.
    Type: Application
    Filed: April 27, 2018
    Publication date: October 11, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Kathleen Dorothy McCarthy, Friedrich Metzger, Hasane Ratni
  • Publication number: 20180289712
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Application
    Filed: April 17, 2018
    Publication date: October 11, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy McCarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse